US 12,251,199 B2
Systems and methods for testing a medical device
Gary A. Freeman, Waltham, MA (US); Shane S. Volpe, Saltsburg, PA (US); Timothy F. Stever, Lowell, MA (US); and Thomas E. Kaib, Irwin, PA (US)
Assigned to ZOLL Medical Corporation, Chelmsford, MA (US)
Filed by ZOLL Medical Corporation, Chelmsford, MA (US)
Filed on May 23, 2023, as Appl. No. 18/322,322.
Application 18/322,322 is a continuation of application No. 17/455,955, filed on Nov. 22, 2021, granted, now 11,701,006.
Application 17/455,955 is a continuation of application No. 16/926,168, filed on Jul. 10, 2020, granted, now 11,213,211, issued on Jan. 4, 2022.
Application 16/926,168 is a continuation of application No. 16/299,277, filed on Mar. 12, 2019, granted, now 10,744,057, issued on Aug. 18, 2020.
Application 16/299,277 is a continuation of application No. 15/073,923, filed on Mar. 18, 2016, granted, now 10,272,010, issued on Apr. 30, 2019.
Claims priority of provisional application 62/135,910, filed on Mar. 20, 2015.
Prior Publication US 2023/0293022 A1, Sep. 21, 2023
Int. Cl. A61B 5/0205 (2006.01); A61B 5/00 (2006.01); A61B 5/11 (2006.01); A61B 5/333 (2021.01); A61H 3/00 (2006.01); A61N 1/39 (2006.01)
CPC A61B 5/0205 (2013.01) [A61B 5/1117 (2013.01); A61B 5/6805 (2013.01); A61B 5/7282 (2013.01); A61B 5/7285 (2013.01); A61H 3/00 (2013.01); A61N 1/39 (2013.01); A61N 1/3904 (2017.08); A61N 1/3925 (2013.01); A61B 5/333 (2021.01); A61B 2560/0242 (2013.01); A61B 2560/0266 (2013.01); A61B 2560/0276 (2013.01); A61N 1/3993 (2013.01)] 21 Claims
OG exemplary drawing
 
1. An ambulatory medical device with self-testing capability, the ambulatory medical device comprising:
a plurality of sensing electrodes configured to detect electrocardiogram signals of a patient;
a plurality of therapy pads configured to deliver one or more treatment shocks to the patient;
a garment configured to be worn by the patient, the garment configured to support the plurality of sensing electrodes and the plurality of therapy pads, such that the plurality of sensing electrodes and the plurality of therapy pads are positioned against the patient when the patient wears the garment;
at least one processor coupled to the plurality of sensing electrodes and the plurality of therapy pads, the at least one processor configured to:
monitor operation of the ambulatory medical device during a device monitoring period during which the ambulatory medical device is continuously operational,
analyze the electrocardiogram signals of the patient during the device monitoring period for one or more treatable cardiac arrhythmia conditions in the patient, wherein the one or more treatable cardiac arrhythmia conditions are treated by one or more of pacing, cardioversion, and/or defibrillation pulses delivered as the one or more treatment shocks to the patient,
detect a self-test triggering event during the device monitoring period based on at least one of an impact event or a vibration event experienced by the ambulatory medical device, and
in response to detecting the self-test triggering event based on the at least one of the impact event or the vibration event, initiate a self-test of the ambulatory medical device.